Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 16705 | 640 | 32.8 | 39% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 522 | 3 | MAGNESIUM-BULLETIN//MAGNESIUM RESEARCH//MAGNESIUM | 20526 |
| 878 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 11463 |
| 16705 | 1 | DEPRESSIVE DISORDER CHEMICALLY INDUCED//DRUG INDUCED DEPRESSION//2 DIMENSIONAL OUTCOME | 640 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | DEPRESSIVE DISORDER CHEMICALLY INDUCED | authKW | 63612 | 0% | 67% | 2 |
| 2 | DRUG INDUCED DEPRESSION | authKW | 63612 | 0% | 67% | 2 |
| 3 | 2 DIMENSIONAL OUTCOME | authKW | 47710 | 0% | 100% | 1 |
| 4 | ADRENOCORTICAL DRUGS | authKW | 47710 | 0% | 100% | 1 |
| 5 | AKATHISIA TARDIVE DYSKINESIA | authKW | 47710 | 0% | 100% | 1 |
| 6 | AMNESTIC DISTURBANCE | authKW | 47710 | 0% | 100% | 1 |
| 7 | ANTIAGGRESSIVE EFFECTS | authKW | 47710 | 0% | 100% | 1 |
| 8 | ARZT NEUROL PSYCHIAT PSYCHOTHER IE | address | 47710 | 0% | 100% | 1 |
| 9 | AVD KLINISK FARMAKOL | address | 47710 | 0% | 100% | 1 |
| 10 | BETA 1 RECEPTOR OCCUPANCY | authKW | 47710 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Psychiatry | 4914 | 32% | 0% | 204 |
| 2 | Pharmacology & Pharmacy | 2722 | 39% | 0% | 248 |
| 3 | Medicine, General & Internal | 868 | 18% | 0% | 116 |
| 4 | Psychology | 188 | 4% | 0% | 27 |
| 5 | Neurosciences | 164 | 12% | 0% | 75 |
| 6 | Clinical Neurology | 102 | 7% | 0% | 45 |
| 7 | Toxicology | 85 | 4% | 0% | 27 |
| 8 | Behavioral Sciences | 79 | 3% | 0% | 19 |
| 9 | Psychology, Clinical | 53 | 3% | 0% | 16 |
| 10 | Primary Health Care | 46 | 1% | 0% | 6 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | ARZT NEUROL PSYCHIAT PSYCHOTHER IE | 47710 | 0% | 100% | 1 |
| 2 | AVD KLINISK FARMAKOL | 47710 | 0% | 100% | 1 |
| 3 | DETP HLTH HUMAN SERV | 47710 | 0% | 100% | 1 |
| 4 | DUKE VET ADM CEREBROVASC NEUROL SECT | 47710 | 0% | 100% | 1 |
| 5 | HOSP GUILAUME REGNIER | 47710 | 0% | 100% | 1 |
| 6 | KLINIKAI KUTATASI MENTALHIGIENES OSZTALY | 47710 | 0% | 100% | 1 |
| 7 | KUTVOLGYI KLINIKAI TOMB | 47710 | 0% | 100% | 1 |
| 8 | NERVOUS SYST NS | 47710 | 0% | 100% | 1 |
| 9 | NEUROL BAA335 | 47710 | 0% | 100% | 1 |
| 10 | NEUROPSZICHOFARMAKOL NEUROKEMIAI KUTATOCSOPORT | 47710 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | PHARMAKOPSYCHIATRIE NEURO-PSYCHOPHARMAKOLOGIE | 10467 | 0% | 7% | 3 |
| 2 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 5992 | 5% | 0% | 32 |
| 3 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2949 | 3% | 0% | 21 |
| 4 | AMERICAN JOURNAL OF PSYCHIATRY | 2150 | 3% | 0% | 20 |
| 5 | DRUGS | 1893 | 2% | 0% | 15 |
| 6 | CLINICAL PHARMACY | 1547 | 1% | 1% | 5 |
| 7 | PSYCHOSOMATICS | 1389 | 1% | 0% | 9 |
| 8 | PROGRESS IN NEURO-PSYCHOPHARMACOLOGY | 1369 | 0% | 1% | 2 |
| 9 | RHODE ISLAND MEDICAL JOURNAL | 1288 | 0% | 3% | 1 |
| 10 | NEUROPSYCHOBIOLOGY | 1272 | 1% | 0% | 8 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | LUIJENDIJK, HJ , KOOLMAN, X , (2012) THE INCENTIVE TO PUBLISH NEGATIVE STUDIES: HOW BETA-BLOCKERS AND DEPRESSION GOT STUCK IN THE PUBLICATION CYCLE.JOURNAL OF CLINICAL EPIDEMIOLOGY. VOL. 65. ISSUE 5. P. 488 -492 | 24 | 96% | 8 |
| 2 | BAILLY, D , (1996) THE ROLE OF BETA-ADRENOCEPTOR BLOCKERS IN THE TREATMENT OF PSYCHIATRIC DISORDERS.CNS DRUGS. VOL. 5. ISSUE 2. P. 115-136 | 63 | 52% | 14 |
| 3 | VERBEEK, DEP , VAN RIEZEN, J , DE BOER, RA , VAN MELLE, JP , DE JONGE, P , (2011) A REVIEW ON THE PUTATIVE ASSOCIATION BETWEEN BETA-BLOCKERS AND DEPRESSION.HEART FAILURE CLINICS. VOL. 7. ISSUE 1. P. 89 -+ | 31 | 54% | 15 |
| 4 | DIMSDALE, JE , NEWTON, RP , JOIST, T , (1989) NEUROPSYCHOLOGICAL SIDE-EFFECTS OF BETA-BLOCKERS.ARCHIVES OF INTERNAL MEDICINE. VOL. 149. ISSUE 3. P. 514-525 | 34 | 79% | 61 |
| 5 | MULDOON, MF , MANUCK, SB , SHAPIRO, AP , WALDSTEIN, SR , (1991) NEUROBEHAVIORAL EFFECTS OF ANTIHYPERTENSIVE MEDICATIONS.JOURNAL OF HYPERTENSION. VOL. 9. ISSUE 6. P. 549-559 | 42 | 57% | 19 |
| 6 | MCAINSH, J , CRUICKSHANK, JM , (1990) BETA-BLOCKERS AND CENTRAL-NERVOUS-SYSTEM SIDE-EFFECTS.PHARMACOLOGY & THERAPEUTICS. VOL. 46. ISSUE 2. P. 163-197 | 54 | 37% | 94 |
| 7 | MULDOON, MF , WALDSTEIN, SR , JENNINGS, JR , (1995) NEUROPSYCHOLOGICAL CONSEQUENCES OF ANTIHYPERTENSIVE MEDICATION USE.EXPERIMENTAL AGING RESEARCH. VOL. 21. ISSUE 4. P. 353-368 | 29 | 59% | 21 |
| 8 | DAHLOF, C , DIMENAS, E , KENDALL, M , WIKLUND, I , (1991) QUALITY-OF-LIFE IN CARDIOVASCULAR-DISEASES - EMPHASIS ON BETA-BLOCKER TREATMENT.CIRCULATION. VOL. 84. ISSUE 6. P. 108-118 | 42 | 47% | 22 |
| 9 | LADER, M , (1988) BETA-ADRENOCEPTOR ANTAGONISTS IN NEUROPSYCHIATRY - AN UPDATE.JOURNAL OF CLINICAL PSYCHIATRY. VOL. 49. ISSUE 6. P. 213-223 | 35 | 61% | 56 |
| 10 | DAHLOF, C , DIMENAS, E , (1990) SIDE-EFFECTS OF BETA-BLOCKER TREATMENTS AS RELATED TO THE CENTRAL-NERVOUS-SYSTEM.AMERICAN JOURNAL OF THE MEDICAL SCIENCES. VOL. 299. ISSUE 4. P. 236-244 | 28 | 72% | 14 |
Classes with closest relation at Level 1 |